625 - 636 of 7680 results

Expert Perspectives: A Treatment Option for Adult Patients with Insomnia

Industry Webcast Sponsored by Eisai; Not for CME/CE Credit


Uncontrolled Asthma: Practical Considerations for Primary Care

Podcast Sponsored by GlaxoSmithKline; Not for CME/CE Credit


Early Recognition of Interstitial Lung Disease

Industry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit

During this virtual Industry Theater presentation, an expert pulmonologist who specializes in the field of interstitial lung diseases (ILDs) will discuss the complexity of ILD recognition, with a focus on diagnostic criteria and the importance of collaborating with specialists for a timely diagnosis of ILDs


Finding an Appropriate Treatment for Anne

Industry Podcast Sponsored by Eisai Inc; Not for CME/CE Credit


Insomnia Insights

Sponsored by Eisai Inc; Not for CME/CE Credit


1 CME CREDIT

This initiative aims to increase understanding among cardiologists about adjunctive LDL-C-lowering therapies and their potential role in reducing residual ASCVD risk. During this series, national lipid expert faculty will discuss the incidence of and diagnostic criteria for statin intolerance, explain the mechanistic rationale for lowering LDL-C through nonstatin therapies, and explore novel targets and treatment pathways. It is expected to improve cardiologists’ management of patients with ‘tough-to-treat’ cholesterol according to the 2018 American Heart Association (AHA)/American College of Cardiology (ACC)/Multi-society Cholesterol Guidelines. Learners will have the opportunity to gain practical clinical perspectives during expert case study discussions. The patient scenarios will discuss how new treatment options may fit into the current therapeutic landscape.


0.36 CME CREDIT

Join primary care physician Dr. Susan Burke and headache specialist Dr. Stewart Tepper, as they review the best practices for communicating with and following patients with migraine. This discussion will include self-management and behavioral strategies for improving migraine symptoms. They will conclude the session with a discussion of three short patient case examples. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 8/31/2020 and they are subject to change as new information is published.


Head Start on Migraine

2.75 CME/MOC
2.81 AANP | 1.67 Pharmacology


0.62 CME CREDIT

This patient case follows the course of a young woman who presents with a complaint of recurrent “sinus” headaches. You will review the proper diagnosis of migraine and, through a series of encounters with the patient, learn to individualize management of episodic migraine, including the use of acute pharmacologic treatment options. Please note that any data, indications, and guidelines presented in this activity are current as of the posting on 6/18/2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the past few years, there have been major advances in the acute treatment of migraine. Multiple medications and devices have recently received FDA-approval, filling some of the unmet treatment needs for patients with migraine. Join primary care physician Dr. Susan Burke and headache specialist Dr. Stewart Tepper, as they review acute treatment strategies and compare older medications with the newer options, including CGRP antagonists, a serotonin 5-HT1F receptor antagonist, and neuromodulation devices. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 8/31/2020 and they are subject to change as new information is published.


1.5 CME CREDITS

In the last year, two new diseases have emerged with significant and lasting impact on the lung: E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and COVID-19 pneumonia. This session will address new information and challenges related to both diseases. Vaping has increased in popularity, especially among youth, and in late 2019, EVALI was first described. While the outbreak has subsided, recognition of the symptoms, association with marijuana use, and radiographic findings of EVALI remain important. Further, providing tobacco and marijuana cessation guidance remains critical. The COVID-19 pandemic, caused by SARS-Cov2 virus, has burdened healthcare workers and scientists across the globe. COVID-19, often associated with severe pneumonia and systemic illness, has resulted in significant morbidity and mortality in the US and we can continue to learn and discover its full impact. Additionally, COVID-19 has unmasked major health disparities in our healthcare system that we must address.


1.5 CME CREDITS

This session will explore some of the most relevant questions clinicians have as we approach a year into the COVID-19 pandemic. Faculty will review the cardiovascular complications that are directly and indirectly attributed to COVID-19 that have been documented since the onset of the pandemic as sequelae of fear leading to avoidance of prescription medication use, emergency department avoidance, and missed routine healthcare. This session will explore “long” COVID-19 and long-term cardiovascular manifestations and population-level health implications. Faculty will compare COVID-19 to influenza and explore how to distinguish presentation of these viruses. Lastly, we will focus on preventative measures including the development of a COVID-19 vaccine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.